Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
INACTIVE COMPANY
 
My Lists

Cygnus  (Stock symbol: CYGN.OB )

400 Penobscot Drive
Redwood City, CA 94063
USA
(650)-369-4300
Website Company Summary Management Team
Team

Outside board: Frank Cary (IBM CEO);  Esther Dyson (Edventure Holdings) Andre Marion (Life Technologies CEO);  Richard Rodgers (Syntex President);  Walter Wriston (CitiCorp CEO)
Company

Business description: Cygnus (www.cygn.com) develops, manufactures and commercializes new and improved glucose-monitoring devices. The Company's products are designed to provide more data to individuals and their physicians and enable them to make better-informed decisions on how to manage diabetes. The GlucoWatch® Biographer was Cygnus' first approved product. The device and its second-generation model are the only products approved by the FDA that provide frequent, automatic and non-invasive measurement of glucose levels. Cygnus believes its products represent the most significant commercialized technological advancement in self-monitoring of glucose levels since the advent of finger-stick blood glucose measurement approximately 20 years ago. The Biographer is not intended to replace the common finger-stick testing method, but is indicated as an adjunctive device to supplement blood glucose testing to provide more complete, ongoing information about glucose levels.
Partners include: ProcterAndGamble;  American Home Products;  JV Wyeth-Ayerst;  Ortho Pharmaceutical;  Park Davis;  Warner Lambert
Capital

Ownership: Public  
Stock Symbol: CYGN.OB
Corporate investors: TVI;  Elf Techologies

Last Tweets


 

Last Mentions


Overview
Record updated: Jan 2005
Sector: Medical
Year Founded: 1984
Ownership: Public  
Stock Symbol: CYGN.OB